← Back to Clinical Trials
Recruiting NCT07251816

NCT07251816 Neural Bases of Motivation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07251816
Status Recruiting
Phase
Sponsor Hospices Civils de Lyon
Condition Healthy Volunteers
Study Type INTERVENTIONAL
Enrollment 204 participants
Start Date 2026-01-14
Primary Completion 2033-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Cortico-cortical paired-associative stimulation (ccPAS)Bifocal transcranial alternating current stimulation (tACS)Combining transcranial temporal interference stimulation (tTIS) and oscillatory TMS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 204 participants in total. It began in 2026-01-14 with a primary completion date of 2033-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Effort-based decisions are essential in daily life but strongly impaired in apathy across various brain disorders. Now, significant research to unveil the neural causes of apathy is needed. A crucial corollary to this is the need to identify the brain network and neural mechanisms underlying effort-based decisions. A fronto-striatal network and the noradrenergic system are involved in effort-based decision-making and apathy. Further, motor cortical structures may play a role in effort-based decision-making. However, the role of circuits connecting the fronto-striatal network and the noradrenergic system to the motor structures has been disregarded so far. Non-invasive brain stimulation methods provide a unique and safe means to test the causal role of connectivity changes between fronto-subcortical and motor structures in effort-based decision-making. It's now necessary to have an integrative, connectionnist framework to uncover the causal role of connectivity changes between fronto-subcortical and motor structures in effort-based decision-making. The overarching goal of the present research protocol is to establish an integrative framework testing the causal role of connectivity within recurrent, bidirectional circuits between fronto-subcortical circuits and motor structures in effort-based decision-making. To achieve this overarching goal, investigators will quantifiy the causal role of effective connectivity and oscillatory synchrony in these circuits on effort-related behavior using a non-invasive brain stimulation strategy. Further, a secondary aim is to identify potential non-invasive brain stimulation methods that could increase engagement in effortful behavior, paving the way for translational clinical applications in the context of apathy. The investigators hypothesize that effort-based decision-making in healthy subjects is governed by bidirectional interactions between fronto-subcortical circuits and motor structures such as the primary motor cortex, mediated by oscillatory synchrony in specific frequency bands (e.g., theta and gamma bands). Accordingly, they hypothesize that transient, non-invasive modulation of connectivity and oscillatory synchrony between these structures in healthy human subjects will directly modulate their decision to engage in effort. Specifically, five experiments will use complementary approaches to test the hypothesis.

Eligibility Criteria

Inclusion Criteria: * Healthy volunteers aged between 18 and 40 years * Participants without confounding factors such as neural alterations related to neurological pathology, whether neurodegenerative (e.g., Alzheimer, Parkinson, Huntington, multiple sclerosis, amyotrophic lateral sclerosis), motor (e.g., dystonia, essential tremors, cerebellar syndrome), traumatic (e.g., traumatic brain injury, medulla lesion) or psychiatric pathologies, whether mood disorders (e.g., depression, bipolarity), anxious troubles (e.g., obsessional compulsive disorder, post-traumatic stress disorder), psychotic (e.g., schizophrenia, delusion), substance-related (e.g., alcool, drug or medicine addiction), food-related (e.g., anorexia, bulimia), neurodevelopmental (e.g., autism, attention-deficit with hyperactivity disorder) or personality (e.g., borderline personality disorder, antisocial personality disorder, obsessive-compulsive disorder). * Participants affiliated with a compulsory social security scheme. Exclusion Criteria: * Persons deprived of liberty by judicial or administrative decisions. * Pregnant women, women in labor or breastfeeding women * Persons admitted to a health or social institution for purposes other than research. * Adults under legal protection measures (e.g., guardianship or curatorship). * Participation in other interventional research with an ongoing non-inclusion period. * Neurological or psychiatric disorders. * Use of tricyclic antidepressants (amitriptyline, clomipramine, imipramine, nortriptyline), neuroleptics (chlorpromazine, haloperidol, risperidone, olanzapine, quetiapine), or recreational drugs within the past 48 hours. * Regular use of recreational drugs. * Sleep deprivation (\< 5 hours regularly over the last 3 months) * Left-handedness or ambidexterity. * Physical injuries impacting motor tasks. * Presence of metal implants in the head (excluding oral fillings). * Presence of implanted medical devices (e.g., pacemaker). * Presence of metallic injuries in the eyes. * Claustrophobia. * Piercings incompatible with MRI procedures. * Contraindication to MRI * Persons who refused to be informed of eventual medical anomalies discovered by the MRI * Personal or family history (first-degree relatives) of epilepsy or seizures. Severe and/or frequent headaches (only for participants receiving transcranial magnetic stimulation, e.g preparatory experience 1 and experience 1) * Baldness impeding electrode placement (only for participants receiving transcranial electrical stimulation and EEG measurements, e.g experiments 2, 3 and 4) * Facial or ear pain and/or recent ear trauma (only for participants receiving transcutaneous vagal nerve stimulation, e.g experiment 5)

Contact & Investigator

Central Contact

Gerard DEROSIERE, Dr

✉ gerard.derosiere@inserm.fr

📞 680872505

Frequently Asked Questions

Who can join the NCT07251816 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07251816 currently recruiting?

Yes, NCT07251816 is actively recruiting participants. Contact the research team at gerard.derosiere@inserm.fr for enrollment information.

Where is the NCT07251816 trial being conducted?

This trial is being conducted at Bron, France.

Who is sponsoring the NCT07251816 clinical trial?

NCT07251816 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 204 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology